Percutaneous coronary intervention (PCI) guided with fractional flow reserve (FFR) in patients with severe aortic stenosis (AS) lowers the risk of major adverse cardiovascular events (MACE) 1-year post-procedure, more so than angiography-guided PCI and optimal medical treatment (OMT), results from a new meta-analysis show.